NCT00354510View on ClinicalTrials.gov

Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

March 31, 2006

Conditions
Atopic DermatitisDermatitis, Atopic
Interventions
DRUG

GW842470X cream

Trial Locations (13)

10117

GSK Investigational Site, Berlin

13125

GSK Investigational Site, Berlin

15831

GSK Investigational Site, Mahlow

20246

GSK Investigational Site, Hamburg

20249

GSK Investigational Site, Hamburg

22143

GSK Investigational Site, Hamburg

22869

GSK Investigational Site, Schenefeld

48249

GSK Investigational Site, Duelmen

51063

GSK Investigational Site, Cologne

86179

GSK Investigational Site, Augsburg

6531 LB

GSK Investigational Site, Nijmegen

3015 GD

GSK Investigational Site, Rotterdam

3584 CJ

GSK Investigational Site, Utrecht

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY